Progesterone Receptor Agonist
Due to the COVID-19 pandemic, the global Progesterone Receptor Agonist market size is estimated t ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drugs for Hormonal Replacement Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Estrogen Replacement Therapy 1.2.3 Human Growth Hormone Replacement Therapy 1.2.4 Thyroid Replacement Therapy 1.2.5 Testosterone Replacement Therapy 1.3 Market by Application 1.3.1 Global Drugs for Hormonal Replacement Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hypothyroidism 1.3.3 Male Hypogonadism 1.3.4 Growth Hormone Deficiency 1.3.5 Menopause 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drugs for Hormonal Replacement Therapy Market Perspective (2017-2028) 2.2 Drugs for Hormonal Replacement Therapy Growth Trends by Region 2.2.1 Drugs for Hormonal Replacement Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Drugs for Hormonal Replacement Therapy Historic Market Size by Region (2017-2022) 2.2.3 Drugs for Hormonal Replacement Therapy Forecasted Market Size by Region (2023-2028) 2.3 Drugs for Hormonal Replacement Therapy Market Dynamics 2.3.1 Drugs for Hormonal Replacement Therapy Industry Trends 2.3.2 Drugs for Hormonal Replacement Therapy Market Drivers 2.3.3 Drugs for Hormonal Replacement Therapy Market Challenges 2.3.4 Drugs for Hormonal Replacement Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drugs for Hormonal Replacement Therapy Players by Revenue 3.1.1 Global Top Drugs for Hormonal Replacement Therapy Players by Revenue (2017-2022) 3.1.2 Global Drugs for Hormonal Replacement Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Drugs for Hormonal Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Drugs for Hormonal Replacement Therapy Revenue 3.4 Global Drugs for Hormonal Replacement Therapy Market Concentration Ratio 3.4.1 Global Drugs for Hormonal Replacement Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drugs for Hormonal Replacement Therapy Revenue in 2021 3.5 Drugs for Hormonal Replacement Therapy Key Players Head office and Area Served 3.6 Key Players Drugs for Hormonal Replacement Therapy Product Solution and Service 3.7 Date of Enter into Drugs for Hormonal Replacement Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drugs for Hormonal Replacement Therapy Breakdown Data by Type 4.1 Global Drugs for Hormonal Replacement Therapy Historic Market Size by Type (2017-2022) 4.2 Global Drugs for Hormonal Replacement Therapy Forecasted Market Size by Type (2023-2028) 5 Drugs for Hormonal Replacement Therapy Breakdown Data by Application 5.1 Global Drugs for Hormonal Replacement Therapy Historic Market Size by Application (2017-2022) 5.2 Global Drugs for Hormonal Replacement Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Drugs for Hormonal Replacement Therapy Market Size (2017-2028) 6.2 North America Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) 6.3 North America Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Drugs for Hormonal Replacement Therapy Market Size (2017-2028) 7.2 Europe Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) 7.3 Europe Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size (2017-2028) 8.2 Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Drugs for Hormonal Replacement Therapy Market Size (2017-2028) 9.2 Latin America Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) 9.3 Latin America Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size (2017-2028) 10.2 Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Novartis AG 11.1.1 Novartis AG Company Detail 11.1.2 Novartis AG Business Overview 11.1.3 Novartis AG Drugs for Hormonal Replacement Therapy Introduction 11.1.4 Novartis AG Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.1.5 Novartis AG Recent Development 11.2 Bayer AG 11.2.1 Bayer AG Company Detail 11.2.2 Bayer AG Business Overview 11.2.3 Bayer AG Drugs for Hormonal Replacement Therapy Introduction 11.2.4 Bayer AG Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.2.5 Bayer AG Recent Development 11.3 Pfizer Inc. 11.3.1 Pfizer Inc. Company Detail 11.3.2 Pfizer Inc. Business Overview 11.3.3 Pfizer Inc. Drugs for Hormonal Replacement Therapy Introduction 11.3.4 Pfizer Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.3.5 Pfizer Inc. Recent Development 11.4 Novo Nordisk A/S 11.4.1 Novo Nordisk A/S Company Detail 11.4.2 Novo Nordisk A/S Business Overview 11.4.3 Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Introduction 11.4.4 Novo Nordisk A/S Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.4.5 Novo Nordisk A/S Recent Development 11.5 Eli Lilly and Company 11.5.1 Eli Lilly and Company Company Detail 11.5.2 Eli Lilly and Company Business Overview 11.5.3 Eli Lilly and Company Drugs for Hormonal Replacement Therapy Introduction 11.5.4 Eli Lilly and Company Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.5.5 Eli Lilly and Company Recent Development 11.6 Abbott 11.6.1 Abbott Company Detail 11.6.2 Abbott Business Overview 11.6.3 Abbott Drugs for Hormonal Replacement Therapy Introduction 11.6.4 Abbott Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.6.5 Abbott Recent Development 11.7 Mylan Laboratories 11.7.1 Mylan Laboratories Company Detail 11.7.2 Mylan Laboratories Business Overview 11.7.3 Mylan Laboratories Drugs for Hormonal Replacement Therapy Introduction 11.7.4 Mylan Laboratories Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.7.5 Mylan Laboratories Recent Development 11.8 Merck & Co. 11.8.1 Merck & Co. Company Detail 11.8.2 Merck & Co. Business Overview 11.8.3 Merck & Co. Drugs for Hormonal Replacement Therapy Introduction 11.8.4 Merck & Co. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.8.5 Merck & Co. Recent Development 11.9 Hisamitsu Pharmaceutical Co. Inc. 11.9.1 Hisamitsu Pharmaceutical Co. Inc. Company Detail 11.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview 11.9.3 Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Introduction 11.9.4 Hisamitsu Pharmaceutical Co. Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.9.5 Hisamitsu Pharmaceutical Co. Inc. Recent Development 11.10 Teva Pharmaceutical Industries Ltd. 11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail 11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.10.3 Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Introduction 11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.11 F.Hoffmann-La Roche 11.11.1 F.Hoffmann-La Roche Company Detail 11.11.2 F.Hoffmann-La Roche Business Overview 11.11.3 F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Introduction 11.11.4 F.Hoffmann-La Roche Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.11.5 F.Hoffmann-La Roche Recent Development 11.12 Noven Pharmaceuticals Inc. 11.12.1 Noven Pharmaceuticals Inc. Company Detail 11.12.2 Noven Pharmaceuticals Inc. Business Overview 11.12.3 Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Introduction 11.12.4 Noven Pharmaceuticals Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.12.5 Noven Pharmaceuticals Inc. Recent Development 11.13 Orion Pharma AB 11.13.1 Orion Pharma AB Company Detail 11.13.2 Orion Pharma AB Business Overview 11.13.3 Orion Pharma AB Drugs for Hormonal Replacement Therapy Introduction 11.13.4 Orion Pharma AB Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.13.5 Orion Pharma AB Recent Development 11.14 Allergan Plc. 11.14.1 Allergan Plc. Company Detail 11.14.2 Allergan Plc. Business Overview 11.14.3 Allergan Plc. Drugs for Hormonal Replacement Therapy Introduction 11.14.4 Allergan Plc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.14.5 Allergan Plc. Recent Development 11.15 QuatRx Pharmaceuticals 11.15.1 QuatRx Pharmaceuticals Company Detail 11.15.2 QuatRx Pharmaceuticals Business Overview 11.15.3 QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Introduction 11.15.4 QuatRx Pharmaceuticals Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.15.5 QuatRx Pharmaceuticals Recent Development 11.16 Wyeth 11.16.1 Wyeth Company Detail 11.16.2 Wyeth Business Overview 11.16.3 Wyeth Drugs for Hormonal Replacement Therapy Introduction 11.16.4 Wyeth Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.16.5 Wyeth Recent Development 11.17 Amgen Inc. 11.17.1 Amgen Inc. Company Detail 11.17.2 Amgen Inc. Business Overview 11.17.3 Amgen Inc. Drugs for Hormonal Replacement Therapy Introduction 11.17.4 Amgen Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.17.5 Amgen Inc. Recent Development 11.18 Roche 11.18.1 Roche Company Detail 11.18.2 Roche Business Overview 11.18.3 Roche Drugs for Hormonal Replacement Therapy Introduction 11.18.4 Roche Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.18.5 Roche Recent Development 11.19 Genentech 11.19.1 Genentech Company Detail 11.19.2 Genentech Business Overview 11.19.3 Genentech Drugs for Hormonal Replacement Therapy Introduction 11.19.4 Genentech Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.19.5 Genentech Recent Development 11.20 TherapeuticsMD 11.20.1 TherapeuticsMD Company Detail 11.20.2 TherapeuticsMD Business Overview 11.20.3 TherapeuticsMD Drugs for Hormonal Replacement Therapy Introduction 11.20.4 TherapeuticsMD Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) 11.20.5 TherapeuticsMD Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Drugs for Hormonal Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Estrogen Replacement Therapy Table 3. Key Players of Human Growth Hormone Replacement Therapy Table 4. Key Players of Thyroid Replacement Therapy Table 5. Key Players of Testosterone Replacement Therapy Table 6. Global Drugs for Hormonal Replacement Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Drugs for Hormonal Replacement Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Drugs for Hormonal Replacement Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Drugs for Hormonal Replacement Therapy Market Share by Region (2017-2022) Table 10. Global Drugs for Hormonal Replacement Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Drugs for Hormonal Replacement Therapy Market Share by Region (2023-2028) Table 12. Drugs for Hormonal Replacement Therapy Market Trends Table 13. Drugs for Hormonal Replacement Therapy Market Drivers Table 14. Drugs for Hormonal Replacement Therapy Market Challenges Table 15. Drugs for Hormonal Replacement Therapy Market Restraints Table 16. Global Drugs for Hormonal Replacement Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Drugs for Hormonal Replacement Therapy Market Share by Players (2017-2022) Table 18. Global Top Drugs for Hormonal Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Hormonal Replacement Therapy as of 2021) Table 19. Ranking of Global Top Drugs for Hormonal Replacement Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Drugs for Hormonal Replacement Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Drugs for Hormonal Replacement Therapy Product Solution and Service Table 23. Date of Enter into Drugs for Hormonal Replacement Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Drugs for Hormonal Replacement Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Drugs for Hormonal Replacement Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Drugs for Hormonal Replacement Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Drugs for Hormonal Replacement Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Drugs for Hormonal Replacement Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Drugs for Hormonal Replacement Therapy Revenue Market Share by Application (2017-2022) Table 31. Global Drugs for Hormonal Replacement Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Drugs for Hormonal Replacement Therapy Revenue Market Share by Application (2023-2028) Table 33. North America Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 43. Novartis AG Company Detail Table 44. Novartis AG Business Overview Table 45. Novartis AG Drugs for Hormonal Replacement Therapy Product Table 46. Novartis AG Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 47. Novartis AG Recent Development Table 48. Bayer AG Company Detail Table 49. Bayer AG Business Overview Table 50. Bayer AG Drugs for Hormonal Replacement Therapy Product Table 51. Bayer AG Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 52. Bayer AG Recent Development Table 53. Pfizer Inc. Company Detail Table 54. Pfizer Inc. Business Overview Table 55. Pfizer Inc. Drugs for Hormonal Replacement Therapy Product Table 56. Pfizer Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 57. Pfizer Inc. Recent Development Table 58. Novo Nordisk A/S Company Detail Table 59. Novo Nordisk A/S Business Overview Table 60. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Product Table 61. Novo Nordisk A/S Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 62. Novo Nordisk A/S Recent Development Table 63. Eli Lilly and Company Company Detail Table 64. Eli Lilly and Company Business Overview Table 65. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Product Table 66. Eli Lilly and Company Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 67. Eli Lilly and Company Recent Development Table 68. Abbott Company Detail Table 69. Abbott Business Overview Table 70. Abbott Drugs for Hormonal Replacement Therapy Product Table 71. Abbott Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 72. Abbott Recent Development Table 73. Mylan Laboratories Company Detail Table 74. Mylan Laboratories Business Overview Table 75. Mylan Laboratories Drugs for Hormonal Replacement Therapy Product Table 76. Mylan Laboratories Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 77. Mylan Laboratories Recent Development Table 78. Merck & Co. Company Detail Table 79. Merck & Co. Business Overview Table 80. Merck & Co. Drugs for Hormonal Replacement Therapy Product Table 81. Merck & Co. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 82. Merck & Co. Recent Development Table 83. Hisamitsu Pharmaceutical Co. Inc. Company Detail Table 84. Hisamitsu Pharmaceutical Co. Inc. Business Overview Table 85. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Product Table 86. Hisamitsu Pharmaceutical Co. Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 87. Hisamitsu Pharmaceutical Co. Inc. Recent Development Table 88. Teva Pharmaceutical Industries Ltd. Company Detail Table 89. Teva Pharmaceutical Industries Ltd. Business Overview Table 90. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Product Table 91. Teva Pharmaceutical Industries Ltd. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 92. Teva Pharmaceutical Industries Ltd. Recent Development Table 93. F.Hoffmann-La Roche Company Detail Table 94. F.Hoffmann-La Roche Business Overview Table 95. F.Hoffmann-La Roche Drugs for Hormonal Replacement TherapyProduct Table 96. F.Hoffmann-La Roche Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 97. F.Hoffmann-La Roche Recent Development Table 98. Noven Pharmaceuticals Inc. Company Detail Table 99. Noven Pharmaceuticals Inc. Business Overview Table 100. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement TherapyProduct Table 101. Noven Pharmaceuticals Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 102. Noven Pharmaceuticals Inc. Recent Development Table 103. Orion Pharma AB Company Detail Table 104. Orion Pharma AB Business Overview Table 105. Orion Pharma AB Drugs for Hormonal Replacement TherapyProduct Table 106. Orion Pharma AB Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 107. Orion Pharma AB Recent Development Table 108. Allergan Plc. Company Detail Table 109. Allergan Plc. Business Overview Table 110. Allergan Plc. Drugs for Hormonal Replacement TherapyProduct Table 111. Allergan Plc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 112. Allergan Plc. Recent Development Table 113. QuatRx Pharmaceuticals Company Detail Table 114. QuatRx Pharmaceuticals Business Overview Table 115. QuatRx Pharmaceuticals Drugs for Hormonal Replacement TherapyProduct Table 116. QuatRx Pharmaceuticals Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 117. QuatRx Pharmaceuticals Recent Development Table 118. Wyeth Company Detail Table 119. Wyeth Business Overview Table 120. Wyeth Drugs for Hormonal Replacement TherapyProduct Table 121. Wyeth Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 122. Wyeth Recent Development Table 123. Amgen Inc. Company Detail Table 124. Amgen Inc. Business Overview Table 125. Amgen Inc. Drugs for Hormonal Replacement TherapyProduct Table 126. Amgen Inc. Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 127. Amgen Inc. Recent Development Table 128. Roche Company Detail Table 129. Roche Business Overview Table 130. Roche Drugs for Hormonal Replacement TherapyProduct Table 131. Roche Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 132. Roche Recent Development Table 133. Genentech Company Detail Table 134. Genentech Business Overview Table 135. Genentech Drugs for Hormonal Replacement TherapyProduct Table 136. Genentech Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 137. Genentech Recent Development Table 138. TherapeuticsMD Company Detail Table 139. TherapeuticsMD Business Overview Table 140. TherapeuticsMD Drugs for Hormonal Replacement TherapyProduct Table 141. TherapeuticsMD Revenue in Drugs for Hormonal Replacement Therapy Business (2017-2022) & (US$ Million) Table 142. TherapeuticsMD Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Drugs for Hormonal Replacement Therapy Market Share by Type: 2021 VS 2028 Figure 2. Estrogen Replacement Therapy Features Figure 3. Human Growth Hormone Replacement Therapy Features Figure 4. Thyroid Replacement Therapy Features Figure 5. Testosterone Replacement Therapy Features Figure 6. Global Drugs for Hormonal Replacement Therapy Market Share by Application in 2021 & 2028 Figure 7. Hypothyroidism Case Studies Figure 8. Male Hypogonadism Case Studies Figure 9. Growth Hormone Deficiency Case Studies Figure 10. Menopause Case Studies Figure 11. Others Case Studies Figure 12. Drugs for Hormonal Replacement Therapy Report Years Considered Figure 13. Global Drugs for Hormonal Replacement Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Drugs for Hormonal Replacement Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Drugs for Hormonal Replacement Therapy Market Share by Region: 2021 VS 2028 Figure 16. Global Drugs for Hormonal Replacement Therapy Market Share by Players in 2021 Figure 17. Global Top Drugs for Hormonal Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Hormonal Replacement Therapy as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Drugs for Hormonal Replacement Therapy Revenue in 2021 Figure 19. North America Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Drugs for Hormonal Replacement Therapy Market Share by Country (2017-2028) Figure 21. United States Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Drugs for Hormonal Replacement Therapy Market Share by Country (2017-2028) Figure 25. Germany Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Drugs for Hormonal Replacement Therapy Market Share by Region (2017-2028) Figure 33. China Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Drugs for Hormonal Replacement Therapy Market Share by Country (2017-2028) Figure 41. Mexico Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Drugs for Hormonal Replacement Therapy Market Share by Country (2017-2028) Figure 45. Turkey Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Drugs for Hormonal Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Novartis AG Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 48. Bayer AG Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 49. Pfizer Inc. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 50. Novo Nordisk A/S Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 51. Eli Lilly and Company Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 52. Abbott Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 53. Mylan Laboratories Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 54. Merck & Co. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 55. Hisamitsu Pharmaceutical Co. Inc. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 57. F.Hoffmann-La Roche Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 58. Noven Pharmaceuticals Inc. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 59. Orion Pharma AB Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 60. Allergan Plc. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 61. QuatRx Pharmaceuticals Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 62. Wyeth Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 63. Amgen Inc. Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 64. Roche Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 65. Genentech Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 66. TherapeuticsMD Revenue Growth Rate in Drugs for Hormonal Replacement Therapy Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Novartis AG Bayer AG Pfizer Inc. Novo Nordisk A/S Eli Lilly and Company Abbott Mylan Laboratories Merck & Co. Hisamitsu Pharmaceutical Co. Inc. Teva Pharmaceutical Industries Ltd. F.Hoffmann-La Roche Noven Pharmaceuticals Inc. Orion Pharma AB Allergan Plc. QuatRx Pharmaceuticals Wyeth Amgen Inc. Roche Genentech TherapeuticsMD
Due to the COVID-19 pandemic, the global Progesterone Receptor Agonist market size is estimated t ... Read More
Market Analysis and Insights: Global Post Menopausal Osteoporosis Drug Market
The g ... Read More
Market Analysis and Insights: Global mRNA Synthesis Service Market
The global mRNA ... Read More
Market Analysis and Insights: Global Biological Safety Testing Product Market
The g ... Read More